Well-Differentiated Lymphocytic Lymphoma
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Well-Differentiated Lymphocytic Lymphoma Means in Everyday Medical Language
Well-Differentiated Lymphocytic Lymphoma, also called Small Lymphocytic Lymphoma (SLL), is a type of slow-growing cancer that affects lymphocytes. Lymphocytes are white blood cells that help your body fight infections. In SLL, too many abnormal lymphocytes build up mainly in the lymph nodes, causing them to become larger than usual. Sometimes, these cancer cells are also found in the blood and bone marrow, and when this happens, the disease is often called chronic lymphocytic leukemia (CLL). Because of this close relationship, SLL and CLL are considered different forms of the same disease. SLL is classified as a type of non-Hodgkin lymphoma, which is a group of cancers that start in the lymph system.
Why the Concept Can Matter in Cancer Care
Knowing that a lymphoma is SLL helps doctors understand how the disease might behave and what treatments could work best. SLL usually grows slowly, which means it may not need immediate treatment and can sometimes be monitored carefully before starting therapy. When treatment is needed, targeted medicines like Acalabrutinib (Calquence) and Zanubrutinib (Brukinsa) are options. These drugs work by blocking specific proteins that cancer cells need to survive and multiply, helping to control the disease. Because SLL is related to CLL, treatments approved for CLL often apply to SLL as well.
What a Patient Might See, Feel, Read, or Be Told When This Term Comes Up
If you or a loved one is diagnosed with SLL, you might hear this term during discussions about diagnosis, test results, or treatment options. It may appear in medical reports, treatment plans, or drug information sheets. You might also hear about related medicines like Calquence or Brukinsa, which are targeted therapies used to treat SLL and related blood cancers. Understanding the term SLL and how it relates to CLL can help you ask your care team questions about your specific diagnosis and treatment choices.
Where the Term Might Appear
SLL may appear in pathology reports, blood test results, treatment plans, or clinical trial information. It can also be listed alongside related terms like chronic lymphocytic leukemia (CLL) or well-differentiated lymphocytic lymphoma. Medications prescribed for SLL, such as Acalabrutinib, Zanubrutinib, or immunotherapies, might be noted in your medical records or pharmacy information. Seeing these terms together is common because they are connected forms of the same disease affecting the lymph system and blood.
What the Term Does Not Automatically Mean
Reading the term SLL does not by itself tell you how serious the cancer is or what treatment you will need. It also does not guarantee a cure or predict how well treatments will work. Each person’s situation is unique, and doctors use additional tests to understand the stage, spread, and behavior of the lymphoma. The term alone is not a treatment recommendation or a full diagnosis.
Common Sources of Confusion and How to Read the Term in Context
The term SLL can be confusing because it is closely linked to chronic lymphocytic leukemia (CLL), and both names may appear in reports or discussions. They describe the same disease but in different locations—SLL mainly in lymph nodes and CLL mainly in blood and bone marrow. Also, SLL may be called well-differentiated lymphocytic lymphoma in some reports. Comparing the exact wording in your medical documents and asking your care team to explain what it means for your situation can help avoid misunderstandings. Remember, seeing the term SLL alone does not tell the whole story about your diagnosis or treatment plan.
Safety and Next Steps
This information is meant to help you understand the term well-differentiated lymphocytic lymphoma and related names. It cannot decide what is safe or appropriate for your care. If you see this term in your medical records or hear it during visits, the best next step is to ask your healthcare team what it means for your specific diagnosis, test results, and treatment options. They can explain how it applies to your situation and help you make informed decisions.
Sources
Public source information used for this glossary entry includes: